The New England journal of medicine | 2019

Personalized Medicine for Primary Treatment of Serous Ovarian Cancer.

 

Abstract


The introduction of “personalized medicine” has spurred major changes in oncology, but success has been spread unevenly across the spectrum of solid tumors. Although prognoses for adenocarcinoma of...

Volume 381 25
Pages \n 2471-2474\n
DOI 10.1056/NEJMe1914488
Language English
Journal The New England journal of medicine

Full Text